Transcriptional regulation of fucosyltransferase 1 gene expression in colon cancer cells

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Taniuchi, Fumiko ^a   Higai, Koji ^a   Tanaka, Tomomi ^a   Azuma, Yutaro ^a   Matsumoto, Kojiro ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 1; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG; ELK1 PROTEIN, HUMAN; GALACTOSIDE 2 ALPHA L FUCOSYLTRANSFERASE; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE; LEWIS Y ANTIGEN;

ARTICLE; BINDING SITE; BLOOD GROUP LEWIS SYSTEM; CANCER CELL; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOASSAY; NUCLEOTIDE SEQUENCE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; COLON TUMOR; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROMOTER REGION; TRANSCRIPTION INITIATION SITE; TUMOR CELL LINE;

BINDING SITES; CELL LINE, TUMOR; COLONIC NEOPLASMS; ENZYME ACTIVATION; ETS-DOMAIN PROTEIN ELK-1; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEWIS BLOOD-GROUP SYSTEM; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS, GENETIC; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84875522080     PISSN: 1537744X     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/105464     Document Type: Article

References (43)

1. Kannagi R., Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-the Warburg effect revisited. Glycoconjugate Journal 2004 20 5 353 364 2-s2.0-2542615352 10.1023/B:GLYC. 0000033631.35357.41 (Pubitemid 39024043)
2. Kannagi R., Carbohydrate antigen sialyl Lewis a-its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Medical Journal 2007 30 3 189 209 2-s2.0-34547765277 (Pubitemid 47235445)
3. Kannagi R., Yin J., Miyazaki K., Izawa M., Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants-Hakomori's concepts revisited. Biochimica et Biophysica Acta 2008 1780 3 525 531 2-s2.0-40749118374 10.1016/j.bbagen.2007.10. 007 (Pubitemid 351381253)
4. Tsuchida A., Okajima T., Furukawa K., Ando T., Ishida H., Yoshida A., Nakamura Y., Kannagi R., Kiso M., Furukawa K., Synthesis of disialyl Lewis a (Lea) structure in colon cancer cell lines by a sialyltransferase, ST6GalNAc VI, responsible for the synthesis of α -series gangliosides. Journal of Biological Chemistry 2003 278 25 22787 22794 2-s2.0-0038604168 10.1074/jbc.M211034200 (Pubitemid 36830340)
5. Kimura N., Mitsuoka C., Kanamori A., Hiraiwa N., Uchimura K., Muramatsu T., Tamatani T., Kansas G. S., Kannagi R., Reconstitution of functional L-selectin ligands on a cultured human endothelial cell line by cotransfection of α 1→3 fucosyltransferase VII and newly cloned GlcNAc β:6-sulfotransferase cDNA. Proceedings of the National Academy of Sciences of the United States of America 1999 96 8 4530 4535 2-s2.0-0033551049 (Pubitemid 29190370)
6. Hakomori S. I., Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochimica et Biophysica Acta 1999 1473 1 247 266 2-s2.0-0032760682 10.1016/S0304-4165(99) 00183-X
7. Bianco T., Farmer B. J., Sage R. E., Dobrovic A., Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood 2001 97 11 3633 3639 2-s2.0-0035383798 10.1182/blood.V97.11.3633
8. Bianco-Miotto T., Hussey D. J., Day T. K., O'Keefe D. S., Dobrovic A., DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients. PLoS One 2009 4 3 2-s2.0-62849092779 10.1371/journal.pone.0004788 e4788
9. Dabelsteen E., Gao S., ABO blood-group antigens in oral cancer. Journal of Dental Research 2005 84 1 21 28 2-s2.0-16644367146 10.1177/154405910508400103 (Pubitemid 43822056)
10. Chihara Y., Sugano K., Kobayashi A., Kanai Y., Yamamoto H., Nakazono H., Fujimoto M., Kakizoe T., Fujimoto K., Hirohashi S., Hirao Y., Loss of blood group A antigen expression in bladder cancer caused by allelic loss and/or methylation of the ABO gene. Laboratory Investigation 2005 85 7 895 907 10.1038/labinvest.3700268 (Pubitemid 41021298)
11. Kominato Y., Hata Y., Takizawa H., Tsuchiya T., Tsukada J., Yamamoto F. I., Expression of human histo-blood group ABO genes is dependent upon DNA methylation of the promoter region. Journal of Biological Chemistry 1999 274 52 37240 37250 2-s2.0-0033601273 10.1074/jbc.274.52.37240 (Pubitemid 30016802)
12. Kawamura Y. I., Kawashima R., Fukunaga R., Hirai K., Toyama-Sorimachi N., Tokuhara M., Shimizu T., Dohi T., Introduction of Sda carbohydrate antigen in gastrointestinal cancer cells eliminates selectin ligands and inhibits metastasis. Cancer Research 2005 65 14 6220 6227 2-s2.0-22244474939 10.1158/0008-5472.CAN-05-0639 (Pubitemid 40994407)
13. Kawamura Y. I., Toyota M., Kawashima R., Hagiwara T., Suzuki H., Imai K., Shinomura Y., Tokino T., Kannagi R., Dohi T., DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer. Gastroenterology 2008 135 1 142 151 2-s2.0-46049114875 10.1053/j.gastro.2008. 03.031 (Pubitemid 351899013)
14. Wang H. R., Hsieh C. Y., Twu Y. C., Yu L. C., Expression of the human Sda β -1,4- N-acetylgalactosaminyltransferase II gene is dependent on the promoter methylation status. Glycobiology 2008 18 1 104 113 2-s2.0-37549070712 10.1093/glycob/cwm120
15. Chandrasekaran E. V., Xue J., Piskorz C., Locke R. D., Tóth K., Slocum H. K., Matta K. L., Potential tumor markers for human gastric cancer: an elevation of glycan:sulfotransferases and a concomitant loss of α 1,2-fucosyltransferase activities. Journal of Cancer Research and Clinical Oncology 2007 133 9 599 611 2-s2.0-34447531767 10.1007/s00432-007-0206-0 (Pubitemid 47077051)
16. Larsen R. D., Ernst L. K., Nair R. P., Lowe J. B., Molecular cloning, sequence, and expression of a human GDP-L-fucose: β -D-galactoside 2- α -L-fucosyltransferase cDNA that can form the H blood group antigen. Proceedings of the National Academy of Sciences of the United States of America 1990 87 17 6674 6678 2-s2.0-0025155469
17. Kelly R. J., Rouquier S., Giorgi D., Lennon G. G., Lowe J. B., Sequence and expression of a candidate for the human Secretor blood group α (1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme- inactivating nonsense mutation commonly correlates with the non-secretor phenotype. Journal of Biological Chemistry 1995 270 9 4640 4649 2-s2.0-0028965558 10.1074/jbc.270.9.4640
18. Orntoft T. F., Greenwell P., Clausen H., Watkins W. M., Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewisb blood group antigens in human colon by α -2-L-fucosylation. Gut 1991 32 3 287 293 2-s2.0-0025976022
19. Koda Y., Soejima M., Kimura H., Structure and expression of H-type GDP-L-fucose: β -D-galactoside 2- α -L-fucosyltransferase gene (FUT1): two transcription start sites and alternative splicing generate several forms of FUT1 mRNA. Journal of Biological Chemistry 1997 272 11 7501 7505 2-s2.0-0030905050 10.1074/jbc.272.11.7501 (Pubitemid 27166464)
20. Koda Y., Soejima M., Kimura H., Changing transcription start sites in H-type α (1,2)fucosyltransferase gene (FUT1) during differentiation of the human erythroid lineage. European Journal of Biochemistry 1998 256 2 379 387 2-s2.0-0031694958 10.1046/j.1432-1327.1998.2560379.x (Pubitemid 28404802)
21. Higai K., Masuda D., Matsuzawa Y., Satoh T., Matsumoto K., A fluorometric assay for glycosyltransferase activities using sugars aminated and tagged with 7-hydroxycoumarin-3-carboxylic acid as substrates and high performance liquid chromatography. Biological and Pharmaceutical Bulletin 1999 22 4 333 338 2-s2.0-0032919741 (Pubitemid 29219973)
22. Higai K., Shibukawa K., Muto S., Matsumoto K., Targeted proteo-glycomics analysis of Sialyl Lewis X antigen expressing glycoproteins secreted by human hepatoma cell line. Analytical Sciences 2003 19 1 85 92 2-s2.0-0037269585 10.2116/analsci.19.85
23. Buchwalter G., Gross C., Wasylyk B., Ets ternary complex transcription factors. Gene 2004 324 1-2 1 14 2-s2.0-0348049997 10.1016/j.gene.2003.09.028 (Pubitemid 38030321)
24. Lehmann U., Brocke P., Dittmer J., Nordheim A., Characterization of the human elk-1 promoter. Potential role of a downstream intronic sequence for elk-1 gene expression in monocytes. Journal of Biological Chemistry 1999 274 3 1736 1744 2-s2.0-0033556439 10.1074/jbc.274.3.1736 (Pubitemid 29057999)
25. Kang R., Saito H., Ihara Y., Miyoshi E., Koyama N., Sheng Y., Taniguchi N., Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. The Journal of Biological Chemistry 1996 271 43 26706 26712 (Pubitemid 26359077)
26. Buckhaults P., Chen L., Fregien N., Pierce M., Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. Journal of Biological Chemistry 1997 272 31 19575 19581 2-s2.0-0030754637 10.1074/jbc.272.31.19575 (Pubitemid 27337760)
27. Pierce M., Buckhaults P., Chen L., Fregien N., Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide β (1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential. Glycoconjugate Journal 1997 14 5 623 630 2-s2.0-0030797268 10.1023/A:1018592627696 (Pubitemid 27353206)
28. Ko J. H., Miyoshi E., Noda K., Ekuni A., Kang R., Ikeda Y., Taniguchi N., Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines. Journal of Biological Chemistry 1999 274 33 22941 22948 2-s2.0-0000656065 10.1074/jbc.274.33.22941 (Pubitemid 29388036)
29. Yamamoto H., Swoger J., Greene S., Saito T., Hurh J., Sweeley C., Leestma J., Mkrdichian E., Cerullo L., Nishikawa A., Ihara Y., Taniguchi N., Moskal J. R., β 1,6-N-acethylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity. Cancer Research 2000 60 1 134 142 2-s2.0-0033621584 (Pubitemid 30058743)
30. Chakraborty A. K., de Frietas Sousa J., Chakraborty D., Funasaka Y., Bhattacharya M., Chatterjee A., Pawelek J., GnT-V expression and metastatic phenotypes in macrophage-melanoma fusion hybrids is down-regulated by 5-Aza-dC: evidence for methylation sensitive, extragenic regulation of GnT-V transcription. Gene 2006 374 1-2 166 173 2-s2.0-33646686860 10.1016/j.gene.2006. 01.031 (Pubitemid 43737122)
31. Withers D. A., Hakomori S. I., Human α (1,3)-fucosyltransferase IV (FUTIV) gene expression is regulated by Elk-1 in the U937 cell line. Journal of Biological Chemistry 2000 275 51 40588 40593 2-s2.0-0034704121 10.1074/jbc.M007262200 (Pubitemid 32064697)
32. Zhu X., Jiang J., Shen H., Wang H., Zong H., Li Z., Yang Y., Niu Z., Liu W., Chen X., Hu Y., Gu J., Elevated β 1,4-galactosyltransferase I in highly metastatic human lung cancer cells: identification of E1AF as important transcription activator. Journal of Biological Chemistry 2005 280 13 12503 12516 2-s2.0-20144389548 10.1074/jbc.M413631200
33. Sato T., Furukawa K., Sequential action of Ets-1 and Sp1 in the activation of the human β -1,4-galactosyltransferase V gene involved in abnormal glycosylation characteristic of cancer cells. Journal of Biological Chemistry 2007 282 38 27702 27712 2-s2.0-34948898708 10.1074/jbc.M611862200 (Pubitemid 47529514)
34. Taniguchi A., Hioki M., Matsumoto K., Transcriptional regulation of human Gal β 1,3GalNAc/Gal β 1, 4GlcNAc α 2,3-sialyltransferase (hST3Gal IV) gene in testis and ovary cell lines. Biochemical and Biophysical Research Communications 2003 301 3 764 768 2-s2.0-0037436228 10.1016/S0006-291X(03)00041-X (Pubitemid 36268955)
35. Kurosawa N., Takashima S., Kono M., Ikehara Y., Inoue M., Tachida Y., Narimatsu H., Tsyji S., Molecular cloning and genomic analysis of mouse GalNAc α 2,6- sialyltransferase (ST6GalNAc I). Journal of Biochemistry 2000 127 5 845 854 2-s2.0-0034127049 (Pubitemid 30317909)
36. Goupille C., Marionneau S., Bureau V., Hallouin F., Meichenin M., Rocher J., Le Pendu J., α 1,2fucosyltransferase increases resistance to apoptosis of rat colon carcinoma cells. Glycobiology 2000 10 4 375 382 2-s2.0-0033625138 (Pubitemid 30184608)
37. Marionneau S., Bureau V., Goupille C., Hallouin F., Rocher J., Vaydie B., Le Pendu J., Susceptibility of rat colon carcinoma cells to lymphokine activated killer-mediated cytotoxicity is decreased by alpha1, 2-fucosylation. International Journal of Cancer 2000 86 5 713 717 (Pubitemid 30249884)
38. Zhang Z., Sun P., Liu J., Fu L., Yan J., Liu Y., Yu L., Wang X., Yan Q., Suppression of FUT1/FUT4 expression by siRNA inhibits tumor growth. Biochimica et Biophysica Acta 2008 1783 2 287 296 2-s2.0-38349027300 10.1016/j.bbamcr.2007. 10.007
39. Zerfaoui M., Fukuda M., Sbarra V., Lombardo D., El-Battari A., α (1,2)-fucosylation prevents sialyl Lewis x expression and E-selectin- mediated adhesion of fucosyltransferase VII-transfected cells. European Journal of Biochemistry 2000 267 1 53 60 2-s2.0-0033980308 10.1046/j.1432-1327.2000.00958.x (Pubitemid 30029737)
40. Mathieu S., Prorok M., Benoliel A. M., Uch R., Langlet C., Bongrand P., Gerolami R., El-Battari A., Transgene expression of α (1,2)- fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin. American Journal of Pathology 2004 164 2 371 383 2-s2.0-1542289800 (Pubitemid 38364653)
41. Miyazaki K., Ohmori K., Izawa M., Koike T., Kumamoto K., Furukawa K., Ando T., Kiso M., Yamaji T., Hashimoto Y., Suzuki A., Yoshida A., Takeuchi M., Kannagi R., Loss of disialyl Lewisa, the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewisa expression on human colon cancers. Cancer Research 2004 64 13 4498 4505 2-s2.0-3042820893 10.1158/0008-5472.CAN-03-3614 (Pubitemid 38856921)
42. Izawa M., Kumamoto K., Mitsuoka C., Kanamori A., Ohmori K., Ishida H., Nakamura S., Kurata-Miura K., Sasaki K., Nishi T., Kannagi R., Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer. Cancer Research 2000 60 5 1410 1416 2-s2.0-0034161897 (Pubitemid 30152015)
43. Kim Y. S., Deng G., Aberrant expression of carbohydrate antigens in cancer: the role of genetic and epigenetic regulation. Gastroenterology 2008 135 1 305 309 2-s2.0-46049085389 10.1053/j.gastro.2008.06.013 (Pubitemid 351899050)